Compassionate use

Improve the follow-up of patients with no treatment alternatives, thanks to early access and compassionate programs for innovative drugs. Carefully supervised by regulatory authorities, surround yourself with a partner who is accustomed to deal with logistical and operational constraints inherent to these projects. Relying on dedicated processes, adapted tools and an agile and specifically trained team, Keyrus Life Science can help you from the definition of the Temporary Use and Data Collection Protocol (PUT-RD) to its operational implementation, and writing the periodic reports.